Is profitability on the horizon for Medical Cannabis’ Leader, Avicanna?

InvestorIntel · Dean Bristow · last updated January 18, 2022 – 4:02 AM

The cannabis sector has had a bit of a rough go over the last year or so, to say the least. In fact, you’d be hard pressed to find a single cannabis name that showed a positive return over the year. That’s why today we are going to have a closer look at Avicanna Inc. (TSX: AVCN | OTCQX: AVCNF). The two business segments I’d like to focus on today are the cosmetic business and the raw materials business. That’s why I’m quite intrigued by Avicanna’s CBD derma-cosmetic products marketed under Pura Health & Wellness (H&W) ™ or Pura Earth™.

here today, more tomorrow

We’ve launched briefing.center with a focus on the press and media.

And we’ve added Citizen Cartwright, a daily quick-read news summary by veteran Washington journalist Linda Cartwright. We’ve also created a new voting rights knowledge center for Citizen Cartwright subscribers. (You can sign up for a dedicated morning email at citizencartwright.com.)

You can sign up here for full access to press and media and Citizen Cartwright on briefing.center.

You can use briefing.center as the center of your information management, or just one of your tools. We’re happy to discuss your information needs.